It is known that HNCHPV+ tumors express p16 due to the negative feedback induced by E7; therefore, assessing p16 expression by immunohistochemistry (IHC) is the most commonly applied test in the clinic to assess the HPV status of the tumor [17]. The gene discussed is CDKN2A; the disease is neoplasm.